// App-Quantinova.ai

P4-13-22 : Successful targeting HER2 in heavily pretreated HER2-negative metastatic breast cancer patients presenting with elevated serum levels of the HER2 extracellular domain and/or HER2 overexpressing circulating tumor cells

Researchers

Presenter

  • Kurbacher CM

Principal Investigators

  • Quade A

  • Eichler C

  • Kunstmann G

  • Herz S

  • Kurbacher JA

  • Warm MR

Medical Centers

  • Krankenhaus Koln-Holweide, Cologne, Germany

  • Brustzentrum, Krankenhaus Holweide, Cologne, Germany

  • Gynecologic Center Bonn-Friedensplatz, Bonn, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Trastuzumab

  • Pertuzumab

  • Lapatinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved